Hitanercept

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHitanercept
Drug Alias NameHitenerceptRecombinant human TNF receptor p75-Fc fusion protein-Shanghai Fudan-ZhangjiangrhTNFR(m):Fc-Shanghai Fudan-ZhangjiangT-0001
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionTumor necrosis factor inhibitors
TargetsTumor necrosis factor
Therapy Area/IndicationsRheumatic DiseasesArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaDiscontinued
Originator CompaniesShanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTaizhou Fudan Zhangjiang Pharmaceutical Co LtdShanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsRheumatic DiseasesArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A